Please wait a minute...
Clinical and Experimental Obstetrics & Gynecology  2018, Vol. 45 Issue (5): 773-774    DOI: 10.12891/ceog4694.2018
Case Report Previous articles | Next articles
The increased cellular permeability syndrome as a cause of traumatic stuttering
J.H. Check1, 2, *(), M. Citerone2, T. Citerone1
1 Cooper Medical School of Rowan University, Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology & Infertility, Camden, NJ
2 Cooper Institute for Reproductive and Hormonal Disorders, P.C., Mt. Laurel, NJ, USA
Download:  PDF
Export:  BibTeX | EndNote (RIS)      
Abstract  
Purpose: To determine if dextroamphetamine sulfate could help post-concussion symptoms, not only of severe headaches but severe stuttering as an additional complication. Materials and Methods: Dextroamphetamine sulfate (part of amphetamine salts) 15 mg extended release capsules was given to a 15-year-old with severe migraine headaches, jaw pain allegedly from temporomandibular joint (TMJ) syndrome, and severe stuttering. Results: The jaw pain and stuttering completely disappeared during the first few days of treatment and the migraines were markedly improved. Conclusion: Post-concussion stuttering can be added to the long list of pathological entities that comprise the increased cellular permeability syndrome, as evidenced by impressive response to sympathomimetic amine therapy.
Key words:  Increased cellular permeability syndrome      Stuttering      Dextroamphetamine sulfate      Concussion      Temporomandibular joint syndrome     
Published:  10 October 2018     
*Corresponding Author(s):  J.H. CHECK     E-mail:  laurie@ccivf.com

Cite this article: 

J.H. Check, M. Citerone, T. Citerone. The increased cellular permeability syndrome as a cause of traumatic stuttering. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(5): 773-774.

URL: 

https://ceog.imrpress.com/EN/10.12891/ceog4694.2018     OR     https://ceog.imrpress.com/EN/Y2018/V45/I5/773

[1] J.H. Check, D. Check. The increased cellular permeability syndrome manifesting as severe idiopathic type urinary incontinence[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(5): 812-814.
[2] J.H. Check, R. Cohen. Sympathomimetic amine therapy abrogates severe long-term unexpalined abdominal pain and diarrhea (microscopic colitis) – possible infertility implications[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(3): 489-491.
[3] J.H. Check, D.L. Check, M.P. Dougherty. Marked improvement of the aromatase induced arthralgia syndrome following treatment with dextroamphetamine sulfate[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(2): 291-292.
[4] J.H. Check, M.P. Dougherty, D.L. Check. Long standing post-herpetic neuralgia resistant to standard anti-neuropathy medication showing quick dramatic improvement following treatment with sympathomimetic amines[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(2): 335-336.
[5] J.H. Check. Changing the name of a syndrome: sympathetic neural hyperalgesia edema syndrome becomes – the increased cellular permeability syndrome[J]. Clinical and Experimental Obstetrics & Gynecology, 2017, 44(6): 819-823.
[6] J.H. Check, R. Cohen. Amelioration of severe generalized idiopathic pruritus in an estrogen deficient woman taking an aromatase inhibitor for breast cancer following treatment with amphetamine salts[J]. Clinical and Experimental Obstetrics & Gynecology, 2017, 44(6): 934-935.
[7] J. H. Check, R. Cohen. Marked improvement of severe gastroparesis following high dosage, but very well tolerated, dextroamphetamine sulfate[J]. Clinical and Experimental Obstetrics & Gynecology, 2017, 44(4): 611-612.
[8] J.H. Check, A. Jaffe. Dextroamphetamine sulfate provided quick relief of severe post-partum depression that was recalcitrant to standard antidepressants and psychotherapy[J]. Clinical and Experimental Obstetrics & Gynecology, 2017, 44(2): 272-274.
No Suggested Reading articles found!